JP2020516615A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516615A5 JP2020516615A5 JP2019554976A JP2019554976A JP2020516615A5 JP 2020516615 A5 JP2020516615 A5 JP 2020516615A5 JP 2019554976 A JP2019554976 A JP 2019554976A JP 2019554976 A JP2019554976 A JP 2019554976A JP 2020516615 A5 JP2020516615 A5 JP 2020516615A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- amino acid
- protein
- host cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023208379A JP2024037834A (ja) | 2017-04-07 | 2023-12-11 | 上皮バリア機能障害の治療のためのタンパク質 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762482963P | 2017-04-07 | 2017-04-07 | |
| US62/482,963 | 2017-04-07 | ||
| US201762607706P | 2017-12-19 | 2017-12-19 | |
| US62/607,706 | 2017-12-19 | ||
| US201762611334P | 2017-12-28 | 2017-12-28 | |
| US62/611,334 | 2017-12-28 | ||
| PCT/US2018/026447 WO2018187682A1 (en) | 2017-04-07 | 2018-04-06 | Proteins for the treatment of epithelial barrier function disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023208379A Division JP2024037834A (ja) | 2017-04-07 | 2023-12-11 | 上皮バリア機能障害の治療のためのタンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516615A JP2020516615A (ja) | 2020-06-11 |
| JP2020516615A5 true JP2020516615A5 (enExample) | 2021-05-13 |
| JP7789303B2 JP7789303B2 (ja) | 2025-12-22 |
Family
ID=63710147
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019554976A Active JP7789303B2 (ja) | 2017-04-07 | 2018-04-06 | 上皮バリア機能障害の治療のためのタンパク質 |
| JP2023208379A Pending JP2024037834A (ja) | 2017-04-07 | 2023-12-11 | 上皮バリア機能障害の治療のためのタンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023208379A Pending JP2024037834A (ja) | 2017-04-07 | 2023-12-11 | 上皮バリア機能障害の治療のためのタンパク質 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10251933B2 (enExample) |
| EP (1) | EP3606542A4 (enExample) |
| JP (2) | JP7789303B2 (enExample) |
| KR (2) | KR102903277B1 (enExample) |
| CN (1) | CN110769844B (enExample) |
| AU (2) | AU2018248324B2 (enExample) |
| CA (1) | CA3059354A1 (enExample) |
| IL (1) | IL269853A (enExample) |
| MX (2) | MX393998B (enExample) |
| SG (1) | SG11201909334TA (enExample) |
| TW (1) | TWI797116B (enExample) |
| WO (1) | WO2018187682A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10251933B2 (en) | 2017-04-07 | 2019-04-09 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11666627B2 (en) | 2017-04-07 | 2023-06-06 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| EP3773644A4 (en) * | 2018-04-06 | 2021-06-02 | Second Genome, Inc. | PROTEINS FOR TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS |
| JP2022512639A (ja) * | 2018-10-09 | 2022-02-07 | セカンド ゲノム インコーポレイテッド | 上皮バリア機能障害の治療に有効なタンパク質を送達するためのラクトコッカス・ラクティス発現系 |
| US20210079086A1 (en) * | 2019-08-21 | 2021-03-18 | Astrazeneca Collaboration Ventures, Llc | Use of Brazikumab to Treat Crohn's Disease |
| EP4087859A4 (en) * | 2020-01-10 | 2024-02-14 | National Taipei University of Technology | PEPTIDE INTERACTING WITH THE TOLL-LIKE RECEPTOR 2 AND COMPOSITION THEREOF |
| CN113773364B (zh) * | 2021-08-25 | 2023-04-28 | 无锡市儿童医院 | 小分子肽及其制备方法和应用 |
| JP2025542567A (ja) * | 2022-11-04 | 2025-12-26 | ミンク セラピューティクス，インコーポレイティッド | Ｂ細胞成熟抗原（ｂｃｍａ）キメラ抗原受容体インバリアントナチュラルキラーｔ細胞及びその用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5571702A (en) | 1991-03-29 | 1996-11-05 | Genentech, Inc. | Amplification method for detection of human PF4A receptors |
| AR053579A1 (es) * | 2005-04-15 | 2007-05-09 | Genentech Inc | Tratamiento de la enfermedad inflamatoria intestinal (eii) |
| ES2568938T3 (es) | 2009-04-28 | 2016-05-05 | Vanderbilt University | Composiciones y procedimientos de tratamiento de trastornos que implican apoptosis de células epiteliales |
| GB201117313D0 (en) * | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| JP2014093482A (ja) | 2012-11-06 | 2014-05-19 | Toshiba Corp | 固体撮像装置の製造方法および固体撮像装置 |
| GB201306536D0 (en) * | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| WO2015014973A2 (en) * | 2013-07-31 | 2015-02-05 | Institut National De La Recherche Agronomique | Use of specific glycoside phosphorylases for the implementation of phosphorolysis or reverse phosphorolysis reactions |
| WO2016203221A1 (en) * | 2015-06-15 | 2016-12-22 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| US10251933B2 (en) | 2017-04-07 | 2019-04-09 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11666627B2 (en) * | 2017-04-07 | 2023-06-06 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11174293B2 (en) | 2017-06-02 | 2021-11-16 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
-
2018
- 2018-04-06 US US15/947,263 patent/US10251933B2/en active Active
- 2018-04-06 CA CA3059354A patent/CA3059354A1/en active Pending
- 2018-04-06 US US16/603,507 patent/US11207376B2/en active Active
- 2018-04-06 KR KR1020237032575A patent/KR102903277B1/ko active Active
- 2018-04-06 AU AU2018248324A patent/AU2018248324B2/en active Active
- 2018-04-06 KR KR1020197032830A patent/KR20200003821A/ko not_active Ceased
- 2018-04-06 EP EP18781398.5A patent/EP3606542A4/en active Pending
- 2018-04-06 CN CN201880037987.0A patent/CN110769844B/zh not_active Expired - Fee Related
- 2018-04-06 JP JP2019554976A patent/JP7789303B2/ja active Active
- 2018-04-06 SG SG11201909334T patent/SG11201909334TA/en unknown
- 2018-04-06 MX MX2019012051A patent/MX393998B/es unknown
- 2018-04-06 WO PCT/US2018/026447 patent/WO2018187682A1/en not_active Ceased
- 2018-04-09 TW TW107112165A patent/TWI797116B/zh active
-
2019
- 2019-10-06 IL IL26985319A patent/IL269853A/en unknown
- 2019-10-07 MX MX2022008842A patent/MX2022008842A/es unknown
-
2023
- 2023-04-24 US US18/305,899 patent/US20240066095A1/en active Pending
- 2023-05-08 AU AU2023202844A patent/AU2023202844A1/en not_active Abandoned
- 2023-12-11 JP JP2023208379A patent/JP2024037834A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020516615A5 (enExample) | ||
| AU2020336649B2 (en) | Akkermansia muciniphila EB-AMDK19 strainand use thereof | |
| US20240066095A1 (en) | Proteins for the treatment of epithelial barrier function disorders | |
| US12168677B2 (en) | Proteins for the treatment of epithelial barrier function disorders | |
| WO2015007216A1 (zh) | 多肽、编码该多肽的dna分子、载体、制备方法及应用 | |
| EP4294210B1 (en) | Methods and compositions using combinations of lactobacillus mucosae and soluble dietary fiber | |
| JP2011225596A5 (enExample) | ||
| JP2014523906A5 (enExample) | ||
| CN113286604A (zh) | 治疗炎症性疾病的蛋白质 | |
| JP2021514354A5 (enExample) | ||
| JP2023517641A5 (enExample) | ||
| US20220257703A1 (en) | Proteins for the treatment of epithelial barrier function disorders | |
| WO2013004069A1 (zh) | 沙门氏菌鞭毛蛋白衍生物在制备防治炎症性肠病药物中的应用 | |
| JP7469812B2 (ja) | 抗微生物特性を有する化合物 | |
| US20210038696A1 (en) | Rectal insulin for treatment of inflammatory bowel diseases | |
| JP2009263307A (ja) | 炎症性腸疾患の予防・治療剤 | |
| CN107951898B (zh) | mir-146a-5p在治疗肠易激综合征内脏高敏感性中的应用 | |
| KR20250138872A (ko) | 비피도박테리움 롱검 rapo를 유효성분으로 포함하는 전신경화증 및 폐섬유증 개선, 예방 또는 치료용 조성물 | |
| CN117017978A (zh) | 香豆素类化合物在制备预防新冠病毒感染引起的肺炎药物中的应用 | |
| CN115429870A (zh) | 白介素40在防治中性粒细胞减少症中的应用 | |
| Warner et al. | Alcohol-induced liver injury is attenuated by human beta defensin in experimental ALD via improvements in the gut-liver axis | |
| CN111281866A (zh) | 一种预防或治疗溃疡性结肠炎的中药化学制剂 | |
| CN110638803A (zh) | Dencichine在制备治疗炎性肠病药物中的用途 | |
| KR20200110684A (ko) | 궤양성 대장염을 앓고 있는 환자를 치료하기 위한 조성물, 및 약물로서의 조성물의 용도 | |
| CN114874311A (zh) | 防御肽及其制备方法和应用 |